SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients (opens in a new tab)
Completed
$8,620 in research paymentsMultiple MyelomaBlood Protein DisordersDexamethasonePomalidomideIsatuximab SAR650984
Dr. Paul G. Richardson, MD
NPI1770544256PAC ID7315975968
- Medicare services, 2024
- 420
- Medicare patients, 2024
- 297
- Part D claims, 2024
- 465
- Clinical trials
- 7
- MIPS score, 2024
- 84
- Practice address
- 450 Brookline Avenue, Boston, MA 02115
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Richardson's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Paul G. Richardson is a hematologist and oncologist in Boston, Massachusetts
Dr. Richardson practices at Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute.
Dr. Richardson's NPI, 1770544256, was assigned on April 1, 2006. Dr. Richardson holds Massachusetts license 78553.
NPI and contact details
- NPI
- 1770544256NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7315975968
- NPI enumeration date
- April 1, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 66
- Medical school graduation
- 1986
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Paul G. Richardson practices at Dana-Farber Cancer Institute in Boston, Massachusetts
Dr. Richardson's primary practice is Dana-Farber Cancer Institute, at 450 Brookline Avenue, Boston, MA 02115.
- Dana-Farber Cancer Institute450 Brookline Avenue, Boston, MA 02115
Source: Dmand AI Affiliation Data
Dr. Paul G. Richardson is affiliated with 5 sites of care and 1 medical group
Dr. Richardson's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dr. Richardson is also affiliated with Massachusetts General Hospital. The medical group on file is Binney Medical Group. Dmand AI also links Dr. Richardson to 2 more hospitals and 1 group practice or clinic, each named with a free account.
Massachusetts General HospitalBinney Medical Group2 hospitalsNames with a free account1 group practice or clinicName with a free account
See all 6 affiliations for Dr. RichardsonSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Paul G. Richardson's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Richardson practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dana-Farber Cancer Institute | Available with a free account |
| +4 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Richardson practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Dana-Farber Cancer Institute and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Paul G. Richardson is one of 429 hematologists and oncologists in Massachusetts
Hematology and oncology is Dr. Richardson's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Richardson is licensed in Massachusetts.
Specialties and state licenses
- Hematology and oncology, MassachusettsPrimary
Hematologists and oncologists near Dr. Richardson
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
429hematologists and oncologists in Massachusetts224hematologists and oncologists in Boston41hematologists and oncologists at Dana-Farber Cancer Institute
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Paul G. Richardson billed Medicare for 420 services in 2024
CMS data shows 420 Medicare services from Dr. Richardson across 4 procedure codes in 2024, for 297 Medicare patients. Medicare paid $49,653 for them.
Medicare services, 2024420
Medicare patients297
Paid by Medicare$49,653
Procedure codes4
Dr. Richardson's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 4282024: 4202%
Where Dr. Richardson's Medicare services took place, 2024
- In an office205%
- In a facility40095%
Dr. Richardson compared with the Massachusetts median for hematologists and oncologists, 2024
- Dr. Richardson
- Massachusetts median
- Medicare services
- 420vs 49515% below
- Medicare patients
- 297vs 20049% above
- Part D claims
- 367vs 1512.4 times
Medians across 415 hematologists and oncologists in Massachusetts with Dmand AI profiles that report each measure.
Dr. Richardson's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Richardson?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Richardson and other hematologists and oncologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Paul G. Richardson treated 297 Medicare patients in 2024, average age 74
CMS counts 297 Medicare patients who saw Dr. Richardson in 2024. The largest group is 65 to 74, with 153 patients. 66% of them have high blood pressure, and 65% have high cholesterol. Their average risk score is 2.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Richardson's median patient age at 72, with 47% women.
Medicare patients, 2024297
Average age74
Average risk score2.90
Dr. Richardson's Medicare patients by age, 2024
Dr. Richardson's Medicare patients by sex, 2024
- Women14549%
- Men15251%
Chronic conditions among Dr. Richardson's Medicare patients, 2024
- High blood pressure66%
- High cholesterol65%
- Arthritis49%
- Chronic kidney disease31%
- Ischemic heart disease26%
- Osteoporosis26%
- Anxiety21%
- Atrial fibrillation19%
Share of Medicare patients with each condition. A patient can have several.
Dr. Richardson's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women47%
- Men53%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Paul G. Richardson wrote 465 Medicare Part D claims in 2024
In 2024, Dr. Richardson wrote 465 Medicare Part D claims for 170 patients. 71% of them were for generic drugs. CMS names the drug for 367 of them, across 8 drugs with 11 or more claims each, at $1,760,735 in total drug cost. In 2023, CMS named 516 claims across 14 drugs.
Part D claims, 2024465
Drugs named by CMS8
Total drug cost$1.8M
Part D patients170
Dr. Richardson's Part D claims by kind of drug, 2024
- Generic332 claims71%
- Brand-name133 claims29%
Dr. Richardson's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Richardson's Part D claims, 2024
- Antibiotics11%53 of 465 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5162024: 36729%
Drugs named by CMS: 8 in 2024, 14 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Paul G. Richardson scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Richardson for performance year 2024, reported as part of a group. Dr. Richardson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Richardson as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Richardson's MIPS scores, performance year 2024
- 84of 100Final score
- 65of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 69of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Richardson by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Paul G. Richardson has worked on 7 clinical trials
Dmand AI links Dr. Richardson to 7 clinical trials. 1 is still active or recruiting. Conditions studied include Multiple Myeloma and Blood Protein Disorders. Sanofi sponsors the most, 3. Open Payments lists research payments to Dr. Richardson that name 8 trials.
Conditions in Dr. Richardson's trials
- Multiple Myeloma
- Blood Protein Disorders
Investigators on the most trials with Dr. Richardson
- Robert Z. Orlowski, MD3 shared trials
- Kenneth Carl Anderson, MD2 shared trials
- Thomas G. Martin, MD2 shared trials
Recent clinical trials with Dr. Richardson
$2,613 in research paymentsMultiple MyelomaBlood Protein DisordersCarfilzomibDexamethasoneisatuximab SAR650984
$1,442 in research paymentsMultiple MyelomaBlood Protein DisordersIxazomib
$192 in research paymentsMultiple MyelomaBlood Protein DisordersBortezomibCarfilzomibDexamethasone
$3,050 in research paymentsMultiple MyelomaBlood Protein DisordersIxazomib Citrate
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Paul G. Richardson received $839,323 in industry payments from 2016 to 2025
CMS Open Payments shows 461 general payments to Dr. Richardson from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. Celgene Corporation paid the most, $159,117. It also lists 101 research payments totaling $246,614 from 2016 to 2024, naming 8 clinical trials.
General payments to Dr. Richardson by program year, 2016 to 2025
General payments to Dr. Richardson by kind, 2016 to 2025
$839.3Kin total
- Consulting fees$467,25056%
- Speaker and faculty fees$165,34420%
- Travel and lodging$146,55318%
- Education$18,2012%
- Other$31,0774%
Companies that paid Dr. Richardson the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Paul G. Richardson's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Paul G. Richardson
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Paul G. Richardson's NPI number?
Dr. Paul G. Richardson's NPI number is 1770544256. It was assigned on April 1, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Paul G. Richardson?
Dr. Paul G. Richardson is a hematologist and oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Paul G. Richardson practice?
Dr. Richardson practices at 450 Brookline Avenue, Boston, MA 02115. Dr. Richardson's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dmand AI also links Dr. Richardson to 2 hospitals and 1 group practice or clinic.
What is Dr. Paul G. Richardson's medical license number?
Dr. Richardson holds Massachusetts license 78553.
Which hospitals is Dr. Paul G. Richardson affiliated with?
Dr. Richardson practices at Dana-Farber Cancer Institute in Boston, Massachusetts. Dr. Richardson is also affiliated with Massachusetts General Hospital. Dmand AI links Dr. Richardson to 2 more hospitals.
What medical group is Dr. Paul G. Richardson part of?
Dr. Richardson is linked to Binney Medical Group.
Does Dr. Paul G. Richardson accept Medicare?
Yes. CMS data shows Dr. Richardson billed Medicare for 420 services in 2024, and Dr. Richardson accepts Medicare assignment.
Does Dr. Paul G. Richardson offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Richardson as offering telehealth services.
What is Dr. Paul G. Richardson's MIPS score?
Dr. Richardson's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
How many Medicare patients does Dr. Paul G. Richardson see?
CMS counts 297 Medicare patients who saw Dr. Richardson in 2024, with an average age of 74.
Show 5 more questionsShow fewer questions
What services does Dr. Paul G. Richardson bill to Medicare?
In 2024, Dr. Richardson's most billed Medicare services were office visit, established patient (99215), office visit, new patient (99205) and office visit, established patient (99214).
What drugs does Dr. Paul G. Richardson prescribe most?
In 2024 Medicare Part D data, Dr. Richardson's most prescribed drugs by claims were Chlorhexidine Gluconate, Revlimid and Clotrimazole.
Has Dr. Paul G. Richardson received payments from drug or device companies?
CMS Open Payments shows $839,323 in general payments to Dr. Richardson from 27 companies from 2016 to 2025. The largest total came from Celgene Corporation.
How long has Dr. Paul G. Richardson been practicing?
Dr. Richardson graduated from medical school in 1986, 40 years ago.
Does Dr. Paul G. Richardson do research?
Dr. Richardson has worked on 7 clinical trials.
Selling to hematology and oncology practices?
See hematologists and oncologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card